Transfusion

Article	Citations
P‐BB‐35 | Evaluating Thrombocytosis in Apheresis Platelet Donors	72
P‐TS‐45 | Improving Blood Transfusion Ordering for Patients with Sickle Cell Disease	62
P‐BB‐53 | Is Average Donor Platelet Count Equivalent to Manufacturer's Recommended Average?	51
P‐BT‐13 | Hematology Analyzer Evaluation for Cellular Therapies	44
P‐TS‐84 | The Incidence of Reported Transfusion Related Acute Lung Injury (TRALI) by Blood Component: A Systematic Review and Meta‐Analysis	35
P‐TS‐11 | An Unusual Case of Transfusion Related Acute Lung Injury	34
OA3‐AM23‐SN‐18 | Routine RBC Reduction of Bone Marrow Products Before Cryopreservation Results in Acceptable Cell Recovery and Viability and does not Affect Engraftment	34
P‐BB‐55 | Lower Cost of Monitoring Leukocyte Reduction QC of Platelets with No Sampling	31
P‐QU‐4 | Impact of Enhancing Criteria for Recognition of Transfusion Reactions	30
Masthead and Table of Contents	29
	28
Cover	27
Abstract Awards	26
Plasma exchange using peripheral arterial and venous access in the pediatric intensive care unit	25
Masthead and Table of Contents	25
Cover	24
Incorrect blood typing and mis‐transfusion due to low‐titer group O whole blood resuscitation	23
P‐TS‐17 | Characterizing the Transfusion Continuum in a Low‐Resource Referral Hospital in Kenya: Developing a Protocol for Emergency Transfusions	23
How did we reform our out of control massive transfusion protocol program?	22
Who donates? Patterns of blood donation and donor characteristics at a university‐affiliated hospital‐based donor center	22
Complement‐mediated hemolysis persists year round in patients with cold agglutinin disease	22
Effective peripheral blood stem cell collection in a 4.6‐kg child	21
Blood safety markers in Dutch donors after relaxation of deferral for men who have sex with men: re‐emergence of syphilis and HIV pre‐exposure prophylaxis use	21
Vesiculation in irradiated and cation‐leaky‐stored red blood cells	21
Life‐threatening hemorrhage as defined by the critical administration threshold in nontraumatic critical bleeding: A descriptive observational study	21

How do I transfer liquid nitrogen freezers to a new home safely?	20
Hematopoietic progenitor cell count as a potential quantitative marker in apheresis products during allogeneic stem cell transplantation	20
Massive transfusion protocol reactivation as a novel marker of physician team under‐triage after injury	19
Collection efficiency and safety of large‐volume leukapheresis for the manufacturing of tisagenlecleucel	18
Effect of major trauma on the expected number of births in Finnish women: A nationwide population‐based public data and register analysis	18
The publication impact of the first 100 THOR Network publications by bibliometric and social network analyses	17
Evaluation of platelets componentized with the Reveos Automated Blood Processing System and stored for 7 days at room temperature in a non‐Di(2‐ethylhexyl) phthalate (DEHP) platelet pooling set	17
Proceedings of the 2022 NHLBI and OASH state of the science in transfusion medicine symposium	17
Hyperbaric treatment of platelets extends in vitro storage to 14 days	17
Relationship between B‐cell epitope structural properties and the immunogenicity of blood group antigens: Outlier properties of the Kell K1 antigen	17
The first two years of the use of low titer group O whole blood during French Military overseas operations: A retrospective study	17
Modeling unrelated blood stem cell donor recruitment using simulated registrant cohorts: Assessment of human leukocyte antigen matching across ethnicity groups	16
Associations between blood donor sex and age, and outcomes of transfused newborn infants	16
HIV incidence in US first‐time blood donors during 12 and 3 month deferral policy periods between 2015 and 2023 before implementation of individual donor assessment	16
A cold case of hemolytic disease of the fetus and newborn resolved by genomic sequencing and population studies to define a new antigen in the Rh system	16
Current advances in transfusion medicine 2021: A critical review of selected topics by the AABB Clinical Transfusion Medicine Committee	16
The senescent antigen hypothesis of RBC evanescence: 50 years of correlation without causation	16
Regulatory T cells: A review of manufacturing and clinical utility	16
Climate change and parasitic risk to the blood supply	16
Sickle cell trait results in a high leukoreduction quality control failure rate for whole blood donations	16
Hemostatics in patients with inhibited coagulation—A viscoelastic in‐vitro analysis	16
Impact of systematic variations in hematocrit and platelet count on thrombelastometry tissue factor activated assay parameters	16
Administration of blood products in the prehospital setting can decrease trauma patient mortality	16
Subject Index	15
Sickle cell disease and the need for blood: Barriers to donation for African, Caribbean, and Black young adults in Canada	15
Abstract Awards	15
Transfusion‐associated adverse events incidence and severity after the implementation of an active hemovigilance program with 24 h follow‐up. A prospective cohort study	15
P‐CB‐5 | CMV Coinfection Enhances RBC Alloimmunization Via a Novel, Type I Interferon‐Independent Mechanism	14
P‐ED‐5 | Providing Advanced Blood Banking Education to Sub‐Saharan Africa: A Project Between a US University and a University in Rwanda	14
P‐TS‐88 | To Wash or Not to Wash: Managing Transfusion Expectations in a Transplant Patient with Severe IgA Deficiency	14
Author Index	14
P‐TS‐29 | Effect of Donor and Recipient Characteristics on Hemoglobin Increments in Intensive Care Unit Patients Receiving Red Blood Cell Transfusion	14
P‐IT‐10 | Improving Donor Experience and Streamlining Blood Donation Process Through a Web‐Based Software Application: A Beta Analysis	14
P‐BB‐19 | Building the Bridge for Prehospital Blood Transfusion: A Standardized Approach from a Blood Center	14
P‐BB‐5 | A New Thermoregulated Container System for Cold Processing of Whole Blood Donations in Extreme Climate Conditions	14
P‐CB‐15 | Lu/BCAM, Lw/ICAM in Polycythemia Vera	13
P‐IS‐5 | Impact of Instrument Uptime Facilitated by Remote Diagnostics in Trauma Centers	13
P‐MG‐1 | Development of A Career Progression Framework for a Donor Screening Laboratory	13
	13
P‐IG‐3 | Prevalence of the Mia Antigen in a Multi‐Ethnic Donor Population	13
P‐TS‐14 | Blood Utilization Trends Among Inpatient US Medicare Beneficiaries Ages 65 and Older, During 2007–2021	13
Masthead and Table of Contents	13
Erratum	13
P‐BB‐11 | Analysis of Donor Moderate and Severe Vasovagal Reactions During Donation on the Alyx Collection Device	13
OA4‐AM23‐ST‐13 | Risk Factors for Active Syphilis Infections in US Blood Donors in the Period 2020–2022	13
Blood group antigens and antibodies in East Asia and their impact on transfusion practice	13
P‐TS‐31 | Evaluation of Potassium Levels in Non‐irradiated and Irradiated Red Cells Units	13
Production of recombinant humanized monoclonal anti‐human neutrophil antigen (HNA) antibodies with potential applicability as standard antibodies	12
Impact of elevated direct factor Xa inhibitor plasma levels on perioperative blood loss in patients undergoing urgent surgery	12
CONTINUING MEDICAL EDUCATION	12

Fatal hemolytic disease of the newborn due to anti‐B Isohemagglutinin: An unfamiliar presentation of a familiar disease	12
Missense RHD single nucleotide variants induce weakened D antigen expression by altering splicing and/or protein expression	12
From pandemic to participation: A two‐year follow‐up of blood donors in the Netherlands who registered during the first wave of the COVID‐19 pandemic	12
A monthly roundup of key articles in other journals	12
A new allele with 303 base pairs insertion in B3GALT1 gene identified in an individual with P1k phenotype	12
Insulin resistance, overweight, and obesity in apheresis donors: A call to reevaluate their eligibility—A prospective cohort study	12
“Are my blood products coming?”: Implementation of a novel blood product tracker in the electronic health record system	12
Prolonged storage of purified granulocyte concentrates: Introduction of a new purification method	12
Perceived risk of HIV transmission by blood transfusion among gay, bisexual, and other men who have sex with men (gbMSM) in Australia	11
Low rate of RNAemia in blood donations collected during the first wave of COVID‐19 in France	11
Reply	11
Rejuvenated and safe: Freeze‐dried plasma for the 21st century	11
Aberrant buffy coat formation during leukodepletion for hyperleukocytosis in a case of primary myelofibrosis‐transforming acute myeloid leukemia	11
A new missense variant in exon 7 of the ABO gene, c.662G>A, in a family with Bw phenotype	11
Reevaluation of the medical necessity of washed red blood cell transfusion in chronically transfused adults	11
NM_000148.4(FUT1):c.[229C>T;302C>T]with 2 missense variations in theFUT1gene associated with a para‐Bombay phenotype	11
Use of KEL‐1 negative red blood cells for emergency release	11
Cryoprecipitate contaminated with Cupriavidus pauculus: A rare cautionary case report	11
Osmotic hemolysis is a donor‐specific feature of red blood cells under various storage conditions and genetic backgrounds	11
Identification of a novel c.259G > T mutation in the ABO*B.01 allele giving rise to a B3 phenotype	11
Systematic review for the serological testing for cold agglutinins: The BEST collaborative study	11
Use of prehospital transfusion by French emergency medical services: A national survey	10
Comparison of manual titrations to automated microplate and gel titration assays used in the screening of blood donors for production of Low‐Titer O Whole Blood	10
Survival in adult patients with chronic primary and secondary immune thrombocytopenia: A population‐based study	10
First report of transfusing low‐titer cold‐stored type O whole blood to an extremely‐low‐birth‐weight neonate after acute blood loss	10
Optimization of biotinylation protocol for next generation studies of red blood cell survival after transfusion	10
	10
Table of Contents	10
Severe neonatal thrombocytopenia due to anti‐HPA‐4b alloantibodies: Third report described in a Caucasian mother	10
Blood component use and injury characteristics of acute trauma patients arriving from the scene of injury or as transfers to a large, mature US Level 1 trauma center serving a large, geogra	10
Use of convalescent plasma inCOVID‐19 patients with immunosuppression	10
Identification of a novel c.77T>G mutation on the ABO*B.01 allele associated with a B subtype	10
Cover	10
P‐BB‐56 | Mitigation Steps to Reduce Platelet Discard Rates due to Aggregates	10
Syphilis‐positive and false‐positive trends among US blood donors, 2013–2023	10
On lower fibrinogen threshold for fibrinogen replacement in plasma exchange: Perhaps for patients with no bleeding risk, but there are more shades of gray	10
Cold‐stored platelets are effective in an in vitro model of massive transfusion protocol assessed by rotational thromboelastometry	10
A novel immunocomplex capture fluorescence assay (ICFA) using fluorescent beads and transfected cells for specific identification of human neutrophil antigen (HNA)‐1a and ‐1b ant	10
Dark brown plasma in healthy blood donor: Art of visual inspection in era of automation	10
Risk of transfusion‐transmitted Babesia microti in Canada	10
Cover Image	10
Hypertension and encephalopathy in a pediatric patient following red blood cell transfusion	10
A narrative review: Resuscitation of older adults with hemorrhagic shock	10
P‐TS‐35 | Group O Red Blood Cell Utilization in Group A recipients with Neonatal Congenital Diaphragmatic Hernia Surgical Repair: A Patient Blood Management Opportunity	9
P‐TS‐61 | Outpatient Transfusions and Transfusion‐Associated Circulatory Overload (TACO) Among US Medicare Beneficiaries, Ages 65 and Older, During 2016‐2022	9
OA3‐AM23‐SN‐22 | “You Don't Know Where [the Blood] Goes”: Findings from Focus Group Discussions with Black/African American Donors and Non‐donors in Southeastern United States	9
OA3‐AM23‐MN‐12 | Residual Leukocytes in Leukoreduced Platelet Products are Required for Humoral Alloimmunization and Platelet Refractoriness in Mice	9
P‐CB‐20 | Preliminary Characterization of Extracellular Vesicles in Intraoperative Cell Salvaged Blood	9
Erratum	9
Comparative analysis of the quality of platelet concentrates produced by apheresis procedures, platelet rich plasma, and buffy coat	9
Anti‐D alloimmunization in Rh(D) negative adults with severe traumatic injury	9
A monthly roundup of key articles in other journals	9
Adding hydroxyurea to chronic transfusion therapy for sickle cell anemia reduces transfusion burden	9
P‐QU‐9 | Validation: Average Number of Correlations Per Assay	9
Critical value reporting of direct antiglobulin testing in newborns: No discernable pattern	9
P‐BT‐18 | Plerixafor‐based Mobilization and Collection of Hematopoietic Stem Cells in Sickle Cell Disease Four Patients in India	9
P‐BB‐62 | Post‐collection Processing of Packed RBCs from Pig	9
OA1‐AM23‐ST‐24 | Cost Savings of Strategic Plan for Distribution of Cold Stored Platelets	9
P‐QU‐8 | Using Quality Improvement to Improve Nurse Completion of Transfusion Orders	9
P‐TS‐79 | Severe Acute Hemolytic Transfusion Reaction in a Pregnant Patient Due to Rare Anti‐Vel	9
Intentional transfusion of expired blood products	9
Mysterious clumping in a cell therapy product	9
E‐learning in transfusion medicine: A scoping review	9
Evolving patterns of first blood product use in trauma in the era of hemorrhage control resuscitation	9
	9
P‐IG‐20 | Evaluation of High‐Density DNA Array Genotyping on African Ancestry Samples	9
P‐TS‐86 | There's a Form for That	9
P‐TS‐60 | Neutrophil Antigen Antibodies Affect Engraftment and Secondary Graft Failure in Hematopoietic Progenitor	9
P‐TS‐27 | Do We Send It Out or Run Selected Cells? A Statistical Evaluation of Panel Efficiency	9
P‐BB‐16 | Assessment of Point‐of‐Care, Rapid Diagnostic Tests for Transfusion Transmissible Infections for a Walking Blood Bank	9
Thank You to Our Reviewers	9
P‐TS‐8 | An Evaluation of Product Usage and Wastage After Implementation of Low‐Titer Group O Whole Blood Products Issued for Patients Under Massive Transfusion Protocol	9
The operational and financial impact of adding anaerobic screening of platelets	9
Assessment of Liaison XL Murex Chagas diagnostic performance in blood screening for Chagas disease using a reference array of chimeric antigens	9
Masthead and Table of Contents	9
P‐PH‐8 | The Evolution and Interpretation of Seroprevalence of SARS‐CoV‐2 Antibodies Among Blood Donors from the Beta to Omicron Variant Driven Waves	9
	9
Plasma transfusion–transmission of Zika virus in mice and macaques	8
Hepatitis A virus (HAV) RNA detection in Polish blood donors and likely transmissions through blood components during the 2017–2019 epidemic	8
A novelSNVon a previously reported hybridRHCEbackground is responsible for an Rh haplotype potentially involved in the generation of an Rh null phenotype	8

Mouse background genetics in biomedical research: The devil's in the details	8
Modeling hemoglobin levels of patients chronically transfused with red blood cells	8
P‐PH‐6 | Regulating Blood Systems in the WHO Eastern Mediterranean Region	8
2023 Oral Abstract Presentation Schedule	8
Blood donor return behavior in South Africa and the United States before and during the COVID‐19 pandemic	8
Sexual risk behavior questions: Understanding and mitigating donor discomfort	8
The novel c.634+4A>G splicing variant inRHCEresults in weak C and e antigen expression in a pregnant woman originated from Japan	8
Transfusion of ABO‐group identical red blood cells following uncrossmatched transfusion does not lead to higher mortality in civilian trauma patients	8
Four novelABO*AWalleles associated with weak antigen expression	8
Identification of a novel nonfunctional FUT1 allele with 967delG in a Chinese para‐Bombay phenotype individual	8
An insertion/deletion polymorphism in the KLF1 gene resulting in an In(Lu) phenotype	8
Durable remission of thrombotic thrombocytopenic purpura in the setting of pembrolizumab therapy	8
Fear is associated with attrition of first‐time whole blood donors: A longitudinal examination of donor confidence and attitude as potential mediators	8
P‐TS‐81 | Successful Surgical Management of Patient with Anti‐Jk3	8
P‐BB‐51 | Increasing Blood Diversity: How Blood Center Websites Tackle Critical Blood Shortages for Sickle Cell Patients Through Recruitment of African‐American Donors	8
OA4‐AM23‐MN‐06 | The Blood System in Ukraine: Experience in Martial Law Conditions	8
Measuring the effectiveness of online search ads on blood donor recruitment and donation	8
Prevalence and clinical implications of heightened plastic chemical exposure in pediatric patients undergoing cardiopulmonary bypass	8
Impact of a post‐donation hemoglobin testing strategy on efficiency and safety of whole blood donation in England: A modeling study	8
Validation of new, gender‐neutral questions on recent sexual behaviors among plasma donors and men who have sex with men	8
Component modifications and acute transfusion reactions: Important then, more to learn now	8
Patterns of transfusion burden in an unselected population of patients with myelodysplastic syndromes: A population‐based study	8
When should RhD‐negative recipients be spared the transfusion of DEL red cells to avoid anti‐D alloimmunization?	8
Commentary on the 1976 Transfusion paper by Aster, Becker, and Filip	8
Subclavian steal syndrome masquerading as a hypotensive transfusion reaction	8
P‐BB‐48 | Improving Platelet Collection Efficiency with Data Management	8
Stored platelet hemostatic phenotype and function is not altered when donors are on testosterone replacement therapy	8
Balancing non‐discriminatory donor selection and blood safety in the Netherlands: Evaluation of an individual risk assessment of sexual behavior	8
Weighing the risk of hemolytic disease of the newborn versus the benefits of using of RhD‐positive blood products in trauma	8
P‐ED‐1 | Development of Competency Assessment Tracker and Training Dashboard Smartsheets	7
OA3‐AM23‐TU‐13 | Platelet Transfusion in Critical Care: A New Method to Analyze Transfusion Practice Based on Decision Time Intervals	7
OA4‐AM23‐MN‐13 | Post‐Transfusion Laboratory Parameters of Patients Transfused with Low Volume Red Blood Cell Products	7
P‐TS‐94 | Trial of INTERCEPT Fibrinogen Complex to Support Massive Transfusion Protocols	7
How do we achieve blinding in modern electronic and paper medical records during the conduct of transfusion trials?	7
Asian‐type DEL (RHD*DEL1) with an allo‐anti‐D: A paradoxical observation in a healthy multiparous woman	7
c.5del mutation on the ABO*B.01 allele responsible for Bx phenotype	7
Gelofusine as alternative to Dextran40‐based solution for washing cryopreserved hematopoietic stem cell products prior to infusion: Validation and application to clinical practice	7
Medicinal leech in the blood bank laboratory plumbing	7
O, wind, if winter comes … will symptoms be far behind?	7
The safety of ABO minor incompatible platelets transfusions using a rapid infuser	7
P‐CB‐22 | Reduction of Anti‐A and Anti‐B Isoagglutinin Titers of Group O Platelet Units with an ABO Antibody Immune Adsorption Column	7
P‐PB‐8 | Blood Components Utilization in Pediatric Cardiac Surgeries at a Tertiary Care Freestanding Children's Hospital in India	7
P‐BT‐2 | A Machine Learning Model for Unstimulated T‐Cell Collection in the Cell Therapy Starting Materials for CAR‐T‐Cell Manufacturing	7
OA1‐AM23‐ST‐23 | Associations Between Platelet Aggregation in Apheresis Units, COVID‐19 Vaccination, SARS‐CoV‐2 Infection Status, and Antibody Levels	7
Masthead and Table of Contents	7
How do I: Evaluate the safety and legitimacy of unproven cellular therapies?	7
Alternatives to blood donor deferral of gay, bisexual, and other men who have sex with men: Acceptability of screening the sexual risk behavior of all blood donors	7
Learning transfusion medicine through scoring objective structured clinical examination	7
A global analysis of the use of immunoglobulin, shortages in supply, and mitigating measures: A survey of hospital providers (a BEST Collaborative study)	7
P‐QU‐7 | Performance Verification of Apheresis Devices in Pediatric Cell Therapy Collection	7
Donors with repeated blood product discards for filtration problems, clots or hemolysis: Causes and follow‐up	7
OA2‐AM23‐MN‐19 | Genetic Loci Containing Immunoregulatory IFIT Genes are Associated with RBC Alloimmunization in an Outbred Mouse Population	7
Weak or discrepant RhD phenotypes: Laboratory management strategies for local patient populations	7
P‐IG‐11 | Apparent RHCE Phenotype Discrepancy in a Mother and Child Due to a Shared RHCE*CE‐D(3‐9)‐CE Allele	7
P‐TS‐15 | Building Downtime Transfusion Label into Routine Labeling Process	7
P‐BT‐5 | Convalescent Plasma (CP) Program for COVID‐19 in Singapore	7
A new platelet alloantigen (Efs2a) on glycoprotein GPIIIa leading to neonatal alloimmune thrombocytopenia	7
Plasma cell‐directed therapy strategies in immune‐mediated thrombotic thrombocytopenic purpura (iTTP)	7
Mortality and morbidity in non‐transfusable and transfusable patients: A systematic review and meta‐analysis	7
An evaluation of the clinical impacts of 7‐day platelets	7
CMV screening of group‐specific orders—good stewardship of the blood supply	7
Increased platelet to red blood cell transfusion ratio associated with acute kidney injury in children with life‐threatening bleeding	7
Post‐exchange neutrophil count, but not post‐hematocrit, predicts endogenous erythropoiesis in patients with sickle cell disease undergoing chronic red cell exchange	7
Red cell transfusion thresholds in outpatients with myelodysplastic syndromes: Results of a pilot randomized trial RBC‐ENHANCE	7
Masthead and Table of Contents	7
Supporting the expansion of organ transplant: Transfusion services handle the details	6
Cover	6
A monthly roundup of key articles in other journals	6
OA3‐AM23‐TU‐03 | Inconsistent Apheresis Collection Parameters for Approved CAR‐T Products: The Role of Study Protocols, Publications and Personnel	6
Impact of iron supplementation among anemic voluntary first‐time blood donors: Results from the BLOODSAFE pilot trial in Ghana	6
Management of perioperative iron deficiency anemia as part of patient blood management in France: A budget impact model‐based analysis based on real world data	6
P‐BT‐26 | Vaccine‐Boosted COVID‐19 Convalescent Plasma Reduces Clinical Disease and Decreases SARS‐CoV‐2 Replication in Lungs Despite Transiently Enhancing Lung Pathology	6
P‐BT‐21 | The Beginning of CAR T Cell in Brazil: Apheresis for T‐cell Collection in Pediatric and Adult Patients	6
P‐IG‐44 | The Relationship Between ABO RH Blood Type and SARS‐CoV‐2 Infection in a Single‐State Multicenter Cohort	6
Hyperviscosity syndrome in Waldenström Macroglobulinemia	6
Masthead and Table of Contents	6
Efficacy of early transfusion of convalescent plasma with high‐titer SARS‐CoV‐2 neutralizing antibodies in hospitalized patients with COVID‐19	6
Successful autologous hematopoietic stem cell transplants using Salmonella positive products collected from asymptomatic donors	6
Impact of input volume on red cell quality in deglycerolized RBCs using a modified ACP‐215 protocol	6
Continuing Medical Education	6
Screening for Zika virus in US armed services blood program donors: An opportunity to compare emerging infectious disease risk between the general US population and military donors	6
P‐BB‐67 | Recruitment of Cannabis Consumers as Blood Donors to Improve Blood Availability.	6
OA2‐AM23‐ST‐24 | Expanded Use of Liquid Plasma in Non‐Emergency Transfusions	6
P‐TS‐21 | COVID‐19 Transmission from Granulocyte Transfusion? A Case Report	6
Allergic reaction to psoralen‐treated platelets: Real or coincidence?	6
OA4‐AM23‐SN‐18 | Source Plasma Collection Using a Novel, Technology‐Enabled Nomogram: A Large‐Scale Real‐World Data Analysis	6
Young apheresis platelet donors show significant and sustained growth over the last decade in the US, 2010–2019: A favorable sign of the resiliency of the platelet supply	6
Patient Blood Management: Why We Need to Change	6
Patterns of platelet use evaluated in EHR networks of the Biologics Effectiveness and Safety Initiative, 2012–2018	6
P‐TS‐40 | Implementation and Quality Analysis of Pathogen Reduced Cryoprecipitated Fibrinogen Complex	6
P‐QU‐5 | Implementation of a Quality Scorecard to Enhance the Culture of Quality	6
P‐IT‐8 | Implementing an Integrated Communication System Between an Apheresis Device and Our Center's Blood Establishment Computer System	6
P‐BB‐18 | Blood Donor Questionnaires and Infectious Disease Screening in Latin American Countries	6
PL5‐AM23‐SN‐30 | The Impact of Non‐Disclosure of Antiretroviral Therapy on HIV Incidence Algorithms	6
Patterns and determinants of blood transfusion in intensive care in Sweden between 2010 and 2018: A nationwide, retrospective cohort study	6